UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Protecting group free radical C-H trifluoromethylation of peptides

Chemical science (Cambridge), 2018, Vol.9 (17), p.4168-4175

2018

Volltextzugriff (PDF)

Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination

Current infectious disease reports, 2018-09, Vol.20 (9), p.30-13, Article 30

2018

Volltextzugriff (PDF)

Unprecedented Reversal of Regioselectivity during Methanolysis and an Interception of Curtius Rearrangement

European journal of organic chemistry, 2021-09, Vol.2021 (36), p.5073-5079

2021

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (16), p.3670-3674

2005

Volltextzugriff (PDF)

3H-[1,2,4] -Triazolo[5,1-i]purin -5 -amine derivatives as adenosine A2A antagonists

Bioorganic & medicinal chemistry letters, 2007-03, Vol.17 (6), p.1659-1662

2007

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (16), p.3675-3678

2005

Volltextzugriff (PDF)

Cyp1 Inhibition Prevents Doxorubicin‐Induced Cardiomyopathy in a Zebrafish Heart‐Failure Model

Chembiochem : a European journal of chemical biology, 2020-07, Vol.21 (13), p.1780-1780

2020

Volltextzugriff (PDF)

Protecting group free radical C-H trifluoromethylation of peptidesElectronic supplementary information (ESI) available. See DOI: 10.1039/c8sc00368h

2018-05

Volltextzugriff (PDF)

Protecting group free radical C–H trifluoromethylation of peptides† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc00368h

Chemical science (Cambridge), 2018-04, Vol.9 (17), p.4168-4175

2018

Volltextzugriff (PDF)

Iminoheterocycles as g-secretase modulators

Bioorganic & medicinal chemistry letters, 2010-09, Vol.20 (18), p.5380-5384

2010

Volltextzugriff (PDF)

3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A sub(2A) antagonists

Bioorganic & medicinal chemistry letters, 2007-03, Vol.17 (6), p.1659-1662

2007

Volltextzugriff (PDF)

3 H-[1,2,4]-Triazolo[5,1- i]purin-5-amine derivatives as adenosine A 2A antagonists

Bioorganic & medicinal chemistry letters, 2007, Vol.17 (6), p.1659-1662

2007

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs : Highly potent, orally active, adenosine A2A antagonists. Part 1: G-protein-coupled receptors in drug discovery

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3670-3674

2005

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5- c]pyrimidin-5-amine analogs: Highly potent, orally active, adenosine A 2A antagonists. Part 1

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3670-3674

2005

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists : The successful reduction of hERG activity. Part 2: G-protein-coupled receptors in drug discovery

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3675-3678

2005

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5- c]pyrimidin-5-amine analogs as adenosine A 2A antagonists: The successful reduction of hERG activity. Part 2

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3675-3678

2005

Volltextzugriff (PDF)

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine Analogues: Highly Potent, Orally Active, Adenosine A2A Antagonists. Part 1

ChemInform, 2006-01, Vol.37 (4), p.no-no

2006

Volltextzugriff (PDF)

action - research on "apathy"

Adult Education, 1955-03, Vol.5 (3), p.157-162

Caldwell, John P.

1955

Volltextzugriff (PDF)

Hedging on the United States futures market by a Canadian producer

Caldwell, John P

1981

Volltextzugriff (PDF)

Lithofacies and Paleontology of Late Paleozoic Allochthonous Deep-Water Carbonates: Example from West Texas Subsurface: ABSTRACT

AAPG bulletin, 1982, Vol.66

Craig D. Caldwell, John P. Hobson

1982

Volltextzugriff (PDF)

Lithofacies and Paleontology of Early Permian, Allochthonous, Deep-Water Carbonates, Reagan and Crockett Counties, Texas--Some Paleogeographic and Exploration Concept Implications: ABSTRACT

AAPG bulletin, 1982, Vol.66

Craig D. Caldwell, John P. Hobson

1982

Volltextzugriff (PDF)

2‐(2‐Furanyl)‐7‐phenyl[1,2,4]triazolo[1,5‐c]pyrimidin‐5‐amine Analogues: Highly Potent, Orally Active, Adenosine A 2A Antagonists. Part 1

ChemInform, 2006-01, Vol.37 (4)

2006

Volltextzugriff (PDF)

The Discovery and Synthesis of Novel Adenosine Receptor (A2A) Antagonists

ChemInform, 2005-07, Vol.36 (28), p.no-no

2005

Volltextzugriff (PDF)

1 – 25 von 493

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(424)
Mit Volltextzugriff
(418)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Protecting group free radical C-H trifluoromethylation of peptides

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9

Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination

Unprecedented Reversal of Regioselectivity during Methanolysis and an Interception of Curtius Rearrangement

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1

3H-[1,2,4] -Triazolo[5,1-i]purin -5 -amine derivatives as adenosine A2A antagonists

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2

Cyp1 Inhibition Prevents Doxorubicin‐Induced Cardiomyopathy in a Zebrafish Heart‐Failure Model

Protecting group free radical C-H trifluoromethylation of peptidesElectronic supplementary information (ESI) available. See DOI: 10.1039/c8sc00368h

Protecting group free radical C–H trifluoromethylation of peptides† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc00368h

Iminoheterocycles as g-secretase modulators

3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A sub(2A) antagonists

3 H-[1,2,4]-Triazolo[5,1- i]purin-5-amine derivatives as adenosine A 2A antagonists

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs : Highly potent, orally active, adenosine A2A antagonists. Part 1: G-protein-coupled receptors in drug discovery

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5- c]pyrimidin-5-amine analogs: Highly potent, orally active, adenosine A 2A antagonists. Part 1

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists : The successful reduction of hERG activity. Part 2: G-protein-coupled receptors in drug discovery

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5- c]pyrimidin-5-amine analogs as adenosine A 2A antagonists: The successful reduction of hERG activity. Part 2

2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine Analogues: Highly Potent, Orally Active, Adenosine A2A Antagonists. Part 1

action - research on "apathy"

Hedging on the United States futures market by a Canadian producer

Lithofacies and Paleontology of Late Paleozoic Allochthonous Deep-Water Carbonates: Example from West Texas Subsurface: ABSTRACT

Lithofacies and Paleontology of Early Permian, Allochthonous, Deep-Water Carbonates, Reagan and Crockett Counties, Texas--Some Paleogeographic and Exploration Concept Implications: ABSTRACT

2‐(2‐Furanyl)‐7‐phenyl[1,2,4]triazolo[1,5‐c]pyrimidin‐5‐amine Analogues: Highly Potent, Orally Active, Adenosine A 2A Antagonists. Part 1

The Discovery and Synthesis of Novel Adenosine Receptor (A2A) Antagonists

Aktive Filter

Suchergebnisse filtern